Yseop Announces Augmented Analyst, the Next-Generation AI NLG Platform Featuring the Most Advanced Intelligent Automation Solution for Streamlined Regulatory Compliance Reporting
Summary
Stemming from the imperative to move away from high-cost individual point solutions, Yseop leveraged over 10 years of experience in the field and invested into an important R&D program, working closely with industry leaders such as Sanofi, Moody’s and BNP Paribas, to develop its Augmented Analyst platform. Built on a unique synergy of advanced AI technologies, Augmented Analyst relies on a powerful industry-leading patented NLG engine and extended NLU and Machine Learning capabilities, to draw insight from structured data, translating them into clearly written reporting narratives. As artificial intelligence is now becoming widely available, Augmented Medical Writer is designed to streamline regulatory submission and enhance human expertise, all while cutting cost and improving efficiency.” Yseop initiated last quarter a series of breakfast briefings “YseopMorning,” inviting users of its technology to share their return of experience with the local community of actual or prospective NLG practitioners. The platform can be deployed on the premises or in private or public cloud, including Amazon Web Services (AWS) YSEOP is an international company specializing in artificial intelligence and a pioneer in natural language text generation (NLG) technology. It is rapidly expanding globally, providing enterprise-level automation solutions for some of the world’s largest companies, including in finance (Credit Agricole, SG, Moody’s, BNP Paribas), pharmaceuticals (Sanofi), and the technology sector (Oracle).